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ASSESSING CONTROL OF ASTHMA IN JUSH, JIMMA, SOUTH 
WEST ETHIOPIA  
 





BACKGROUND: Despite international guidelines, asthma control is short of the goal in different parts 
of the world. The objective of this study was to assess control of asthma in patients older than 14 years at 
the Chest Clinic of Jimma University Specialized Hospital/JUSH, South West Ethiopia. 
METHODS: A cross-sectional hospital-based study was conducted on 234 physician-diagnosed 
asthmatic patients attending the chest follow up clinic from June 01 to July 31, 2012. Asthma control 
was assessed using the GINA algorithm and the ACT questionnaire. Pulmonary function test was 
measured using a spirometer for 160 subjects. Data were cleared, entered and analyzed using SPSS 
version 16 and independent variables were assessed for association with the level of asthma control using 
bivariate and multinomial analyses.  
RESULTS: Using the GINA based algorithm, 42 respondents (26.2%) were considered to have partly 
controlled asthma and the majority, 117 (76.1%), had uncontrolled asthma. Asthma was uncontrolled 
(ACT score <19) in 71.4% subjects and well-controlled (ACT score = 20-25) in 28.6%. Inhaled 
corticosteroids alone or in association with long-acting b-agonists, which are the prophylactic treatments 
recommended by GINA, were used by only 9 subjects (3.8%). Factors associated independently with 
asthma control were individual patient’s age group, unscheduled visit, frequency of SABA use, type of 
treatment and perceived rate of asthma control. 
CONCLUSION: Asthma control is unacceptably poor in Jimma, South West Ethiopia. This could be 
changed through improved appropriate treatment and frequent monitoring to achieve and maintain 
control. 






Asthma is a chronic inflammatory disorder of the 
airways. Chronically, inflamed airways are hyper-
responsive-they become obstructed and airflow is 
limited by broncho-constriction, mucus plugs, and 
increased inflammation when airways are exposed 
to various risk factors. The goal of asthma 
treatment is to achieve and maintain clinical 
control that can be reached in most patients 
through a continuous cycle that involves assessing 
asthma control, treating to achieve control, and 
monitoring to maintain control(1). Asthma control 
can be broken down into two domains: 
impairment and risk. Impairment is an assessment 
of the frequency and intensity of symptoms and 
functional limitations that a patient is experiencing 
or has recently experienced. Risk is an estimate of 
the likelihood of either asthma exacerbations or of 
progressive loss of pulmonary function over time 
(2).  
There are different validated measures for 
assessing impairment to determine control of 
asthma, one of which is The Global Initiative for 
Asthma (GINA) guideline which has proposed six 
criteria for evaluating asthma control. Controlled 
asthma is defined by the absence of daytime 
symptoms (no more than twice a week), the  
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absence of night-time symptoms, no limitations in 
activities, no need for rescue medication (no more 
than twice a week), normal lung function 
(measured as forced expiratory volume in one 
second or peak expiratory flow) and no 
exacerbations(3).  
The validated and international asthma 
control test (ACT) questionnaire has also been 
developed to facilitate and standardize the 
assessment of the impairment domain of asthma 
control. The ACT survey is a patient-completed 
questionnaire with 5 items assessing asthma 
symptoms (daytime and nocturnal), use of rescue 
medications, and the effect of asthma on daily 
functioning. Each item includes 5 response 
options corresponding to a 5-point rating scale. In 
scoring the ACT survey, responses for the 5 items 
are summed to yield a score ranging from 5 (poor 
control of asthma) to 25 (complete control of 
asthma.8%). A cut-off point <1 was used for under 
control of asthma which has a sensitivity of 71.3% 
and specificity of 70. ACT scores also correlated 
significantly with baseline percent predicted 
Forced Expiratory Volume in one second (FEV1) 
(4).   
Exacerbations of asthma are episodes of a 
progressive increase in shortness of breath, cough, 
wheezing, or chest tightness, or a combination of 
these symptoms requiring systemic steroids or 
emergency department visits and admission (1).  
Assessment of the risk of exacerbations can 
be inferred from the medical history. Patients who 
have had exacerbations requiring emergency 
department (ED) visits, hospitalization or 
intensive care unit (ICU) admission, especially in 
the past year, have a great risk of exacerbations in 
the future (2).   
The test most used for assessing the risk of 
future adverse events is spirometry, especially 
forced expiratory volume in 1 second (FEV1) 
expressed as a percent of the predicted value or a 
proportion of the forced vital capacity (FVC) or 
FEV1/FVC. A low forced expiratory volume in 
one second (FEV1) is associated with an increased 
risk of asthma exacerbations-the lower the FEV1, 
the greater the risk (5). 
 
METHODS AND MATERIALS 
 
The study was carried out in Jimma University 
Specialized Referral Hospital (JUSH), one of the 
prestigious teaching medical institutions of the 
country. The hospital, as a referral center for 15 
million populations in the Southwest region of 
Ethiopia, gives health service at inpatient and 
outpatient levels. It has one chest clinic. There are 
833 patients with regular follow-up in the clinic 
currently. Of these, 331 are males while 502 are 
females. A cross-sectional hospital-based survey 
was conducted from June 1, 2012 to July 31, 2012. 
Physician diagnosed asthmatic patients with 
follow-up at the chest clinic and taking 
medications for their asthma, both male and 
female aged >14 years, were included in the study. 
Pregnant ladies were excluded from the study due 
to variable effects of pregnancy on bronchial 
asthma. Patients with diagnosis other than asthma 
such as physician diagnosed COPD, 
bronchiectasis, lung cancer, and cardiac illness 
were also excluded due to confounding effects. 
Patients with significant respiratory distress due to 
an exacerbation that required emergency 
department visit or admission were not included in 
the study as they are not able to perform 
spirometric measurement. 
The sample was calculated using the single 
population formula assuming control of asthma to 
be 50%, margin of error 5%, and 95% confidence 
interval. Accordingly, calculated sample size was 
384. Since the source population was less than 
10,000, correction factor to determine the final 
sample size was used, and the sample became 263. 
Consecutive sampling of clients coming to the 
clinic on their appointment dates was conducted. 
Pulmonary function test was carried out using a 
spirometer for 160 subjects (68%) of the total 
sample size who came to the chest clinic 
consecutively on the day of appointment. 
Asthma control was assessed in two ways: 
using the GINA classifications scheme and ACT 
score. The characteristics of GINA clinical 
classification used in the study were daytime 
symptoms, nocturnal symptoms, need for reliever 
medication, limitation of activity, number of 
exacerbations and lung function test, FEV1(1).  
For patients whose lung function test was not 
determined, only the five components of GINA 
algorithm, excluding the FEV1 was used to assess 
control of asthma separately. 
The validated and international asthma 
control test (ACT) questionnaire was used to 
assess the control of asthma. The ACT survey is a 




patient-completed questionnaire with 5 items 
assessing asthma symptoms (daytime and 
nocturnal), use of rescue medications and the 
effect of asthma on daily functioning. Each item 
includes 5 response options corresponding to a 5-
point rating scale. In scoring the ACT survey, 
responses for each of the 5 items were summed to 
yield a score ranging from 5 (poor control of 
asthma) to 25 (complete control of asthma). A cut-
off point <19 was used for under control of asthma 
(2).  
Patients were also classified into four severity 
categories using the NAEPP 2007 classification 
system as mild intermittent, mild persistent, 
moderate persistent, and severe persistent asthma. 
Data for this study were collected through patient 
interview using a structured questionnaire 
containing socio-demographic characteristics, 
asthma symptoms, type and frequency of 
treatment, number of exacerbations, and certain 
predictors of asthma control were used to assess 
control of asthma.   
Pulmonary function test was determined that 
generates FEV1 and FEV/FVC. A portable mini-
digital spirometer (DATOSPIR-120-Model-D 
designed by SIBELMED) was used. It has its own 
disposable mouth piece and a connecting tube.  
A trained nurse entered correct values for 
age, height and gender as these values are used to 
generate the appropriate predicted values for the 
individual patient. Height was measured with 
shoes off. Body weight was also measured to 
calculate the body mass index. 
The patients were seated during spirometry. 
They were instructed to hold their nose with their 
first two fingers to prevent air leakage through 
their nasal passages. Deep inhalation occurred 
before the mouthpiece was placed in the mouth. 
Immediately after the deep inhalation, the 
mouthpiece was placed just inside the mouth 
between the teeth. The lips were sealed tightly 
around the mouthpiece to prevent air leakage 
during maximal forced exhalation. Three 
maneuvers were performed, and the highest 
spirometric value was taken for analysis. 
Universal pre-requisitions of performing 
spirometric assessment were carried out. 
A total of four nurses who were working at the 
chest follow-up clinic were involved in the study 
after they were trained on how to fill the 
structured questionnaire. Two of the nurses were 
also trained on how to perform the spirometer. 
The principal investigator supervised the overall 
activities during data collection. 
SPSS statistical software, Version 16.0 was 
used for data analysis. Inter-group comparisons 
were performed with the chi-square test or 
Fisher’s Exact Test for categorical variables. The 
variables reported on the questionnaire were 
assessed for association with the level of asthma 
control. In a first step, each variable was evaluated 
independently in a bivariate analysis. Next, all 
variables associated with the level of asthma 
control at a probability level of 0.25 in one or 
other of the univariate analyses were entered into a 
multinomial logistic regression analysis. Variables 
were retained in the model in an ascending 
stepwise manner to generate odds ratio and 
determine those that were independently 
associated with the level of asthma control at a 
probability level of 0.05.  
The data were checked for completeness and 
consistency on the day of collection. Standards of 
procedures during spirometry were re-checked by 
the principal investigator. Ethical clearance was 
obtained from Ethical Committee of Jimma 
University. The willingness and verbal informed 
consent were obtained from the study participants 




Overall, 234 individuals (89% of the calculated 
sample size) fulfilled the eligibility criteria and 
were included in the study. Of these, spirometry to 
generate the FEV1 was done for 160 (68%) 
subjects. 
Daytime asthma symptoms that occurred 
daily were reported by 80 (34.2%) of the subjects, 
and night time asthma symptoms occurred 7 times 
per week in 94 (40.2%) subjects. Eighty-nine 
(38%) individuals used SABA more than twice 









Table 1: Socio-demographic and health characteristics of subjects with asthma, Chest Clinic JUSH, 2012 
  
Variable                   (n=234)  No % 
Age 
Mean± SD= 41.41 ± 15.194 
  
Median(Range) = 40(14-82)   
   14-34 77 32.9 
   35-54 99 42.3 
   >=55 58 24.8 
Sex   
   Male 103 44 
   Female 131 56 
Living place   
   Urban 217 92.7 
   Rural area 17 7.3 
Smoking   
   Yes 7 3.0 
   No 227 97.0 
Co morbid illness   
   Yes 75 32.1 
   No 159 67.9 
BMI   
   < 18 54 23.1 
   18-25 131 56.0 
   25-30 34 14.5 
   > 30 15 6.4 
Educational level    
   Illiterate 65 27.8 
   Primary 58 24.8 
   Secondary 63 26.9 
   Higher education 48 20.5 
Frequency of daytime Asthma 
symptoms  
  
   None 21 9.0 
   <2 days/week 42 17.9 
   >2 days/week 76 32.5 
   Daily 80 34.2 
   Throughout the day 




…Table 1. Continued 
Variable                   (n=234) No % 
Night time Asthma symptoms   
   None 33 14.1 
   1-2/month 14 5.9 
   3-4/month 41 17.5 
   >1/week 52 22.2 
   7 times/week 94 40.2 
Frequency of SABA use   
   None 110 47.0 
   <=2days/week 35 15.0 
   >2 days/week 39 16.7 
   Several times/day 50 21.4 
Limitation of activity   
  None 70 29.9 
  Any 164 70.1 
Perceived control of asthma   
   Uncontrolled 150 64.1 
   Controlled 84 35.9 
Exacerbation   
   Yes 24 10.3 
   No 210 89.7 
Unscheduled visit    
   Yes  73 31.2 
   No 161 68.8 
Hospital admission   
   Yes  29 12.4 
   No  205 87.6 
FEV1   
   >= 80% 23 14.4 
   60-80% 47 29.4 
   < 60% 90 56.2 
Family history Bronchial Asthma   
   Yes 61 26.1 
   No 173 73.9 
Asthma Control ACT   
   Well Controlled 67 28.6 
   Not Well Controlled 49 20.9 
   Very Poorly Controlled 118 50.4 
Asthma control was initially assessed using the 
GINA algorithm, and based on this method, 42 
respondents (26.2%) were considered to have 
partly controlled asthma and the majority, 117 
(73.1%), had uncontrolled asthma. Since 
spirometry was done only for 68% of the 
participants, asthma control using the GINA 
algorithm was done also for all the 234 patients 
excluding the lung function test component. Based 
on this method, asthma control was considered 
better than the one with lung function test (Fig 1). 
 






Fig.1: Proportion of subjects assigned to three different control groups using the GINA based algorithm with and 
without LFT, Chest Clinic, JUSH, 2012. 
 
Asthma control was also assessed using the ACT 
score for all 234 individuals; 118 subjects (50.4%) 
scored less than or equal to 15 that corresponds to 
very poorly controlled asthma, and only 
67(28.6%) scored 20 and more than 20 out of 25 
that corresponds to well controlled (Table 1). 
       Overall, 130(55.6%) individuals used short 
acting beta agonist (SABA) inhaler medication for 
quick relief of their asthma symptoms. Inhaled 
corticosteroids alone or in association with long-
acting b-agonists, which are the prophylactic 
treatments recommended by GINA, were used by 
only 9 subjects (3.8%). Oral corticosteroid was 
used by 28.6% of the individuals overall and use 
of theophedrine accounted for 17.5% of the 
asthmatic individuals (Fig. 2). Further analysis of 
treatment revealed that multiple drug therapy (two 
drugs 43.6%, three drugs 17.9%) was opted for a 
significant number of patients as compared to 
single drug therapy (29.9%). Oral and inhaler 
SABA medications were the two most often 




Fig.2: Proportion of subjects by type of treatment, 2012 chest clinic JUSH. (Multiple responses were possible). 





Only 1% of the patients with severe persistent 
asthma used a controller medication, which was an 
inhaled corticosteroid. At the same time, use of 
quick-relief medication such as a SABA was high 
in this group (85%), which is suggestive of poor 
asthma control. Patients with intermittent asthma 





Fig.3: Use of medication by type of asthma severity, 2012 chest clinic JUSH. 
        
Bivariate analysis identified a number of variables 
featured in the questionnaire as being associated 
with asthma control. Six of these were associated 
with control at a probability threshold of p<0.05, 
and additional four variables at a probability level 
of p<0.25, which was the threshold required for 
entry into the multinomial analysis. These 
variables are listed in Table 3. The six variables 
with the strongest association with asthma control 
(p<0.05) were living place, BMI, unscheduled 
visit in the past one year, type of treatment for 
asthma, personal rate of asthma control in the past 
four weeks and underlying asthma severity. The 
four variables at probability level of p<0.25 were 
age of the individual asthmatic patient, smoking 
history, presence of co-morbid illness and hospital 
admission in the past one year (Table 2). 
All the ten variables retained were entered 
into a stepwise multinomial logistic regression 
analysis with retained five factors that were 
independently associated with asthma control. 
These were age group, frequency of unscheduled 
visit, use of inhaler SABA and OCS medications 
and personal rate of asthma control. Probability of 
getting well-controlled asthma was more than 
three times higher in the age group of 14-34 years 
than other older age groups, p=0.048 (OR=3.445 
95% CI (1.009-11.766)). Asthma was less well-
controlled in those patients with more unscheduled 
visit p=0.002 (OR=0.197 95% CI (0.070-0.555)), 
in those using frequent SABA p=0.001 (OR=0.19 
95% CI (0.074-0.488)), OCS use p=0.011 
(OR=0.247 95% CI (0.084-0.728)) and those who 
perceived their asthma is under controlled, 
p<0.001 (OR=0.051 95% CI (0.020-0.128)) as 


















Table 2:  Demographic and health characteristics of subjects with asthma by control status using ACT Questionnaire 
(n=234), 2012 chest clinic JUSH. 
 








   14-34 
    
    27(35.1) 20(26.0) 30(39.0) 0.172 
   35-54 25(25.3) 17(17.2) 57(57.6)  
   >=55 15(25.9) 12(20.7) 31(53.4)  
Living place     
   Urban 65(30.0) 41(18.9) 111(51.2) 0.017 
   Rural area 2(11.8) 8(47.1) 7(41.2)  
BMI     
   < 18 12(22.2) 6(11.1) 36(66.7) 0.032 
   18-25 41(31.3) 34(26) 56(42.7)  
   25-30 7(20.6) 8(23.5) 19(51.9)  
   > 30 7(46.7) 1(6.7) 7(46.7)  
Smoking     
   Yes 1(14.3) 0(0) 6(85.7) 0.149 
   No 66(29.1) 49(21.6) 112(49.3)  
Co morbid Illness      
   Yes 26(34.7) 10(13.3) 39(52.0) 0.105 
   No 41(25.8) 39(24.5) 79(49.7)  
Hospital admission 
past one year 
    
   Yes 6(20.7) 3(10.3) 20(69.0) 0.093 
   No 61(29.8) 46(22.4) 98(47.8)  
Unscheduled visit     
   Yes 9(12.3) 11(15.0) 53(72.6) 0.000 
   No 58(36.0) 38(23.6) 65(40.4)  
Type Treatment     
SABA oral -Yes 31(22.6) 26(19.0) 80(58.4) 0.012 
                     No 36(37.1) 23(23.7) 38(39.2)  
 SABA inhaler-Yes 20(15.4) 23(17.7) 87(66.9) 0.000 
                           No 47(45.2) 26(25.0) 31(29.8)  
  OCS-Yes 9(13.2) 13(19.1) 46(67.6) 0.001 
            No 58(34.9) 36(21.7) 72(43.4)  
  Antihistamine-Yes 7(43.8) 6(37.5) 3(18.8) 0.03 
                             No 60(27.5) 43(19.7) 115(52.8)  
Personal rate      
   Uncontrolled 18(12.0) 34(22.7) 98(65.3) 0.000 
   controlled 49(58.3) 15(17.9) 20(23.8)  
 





Table 3: Predictors of Asthma Control multinomial analysis, Chest Clinic, JUSH, August 2012 (Well 
controlled vs. poorly controlled) 
 
        Control of Asthma          OR 




           
 No (%) 
Very poorly 
controlled 




14-34 27 30 3.445(1.009-11.766) .048 
35-55 25 57 1.700(0.546-5.295) .365 




Yes 6 20 0.509(0.120-2.166) .361 




Yes 9 53 0.197(0.070-0.555) .002 
No 58 65   
Oral SABA use 
 
 
Yes 31 80 0.774(0.304-1.968) .590 
No 36 38   
Inhaler SABA use 
 
 
Yes 20 87 0.190(0.074-0.488) .001 
No 47 31   
OCS use  Yes 9 46 0.247(0.084-0.728) .011 
No 58 72   
Antihistamine use Yes 7 3 1.903(0.339-10.696) .465 
No 60 115   
BMI <18 12 36 0.719(0.092-5.594) .752 
18-25 41 56 0.926(0.141-6.070) .936 
25-30 7 19 0.395(0.050-3.137) .379 
>30 7 7   
Co morbid illness Yes 26 39 1.286(0.508-3.255) .596 
No 41 79   
Personal rate of 
asthma control 
Yes 18 98 0.051(0.020-
0.128) 
.000 




The principal finding of this study is that asthma 
control in the chest clinic of JUSH is poor. Using 
the GINA based algorithm, 73.1% of the 
respondents were classified as having uncontrolled 
asthma and 42 (26.2%) as having partly controlled 
asthma. Controlled asthma was documented in 
less than 1% of the subjects. But, when GINA 
based algorithm excluding PFT was used to assess 
asthma control, results were better. Only 79 
(33.8%) individuals had uncontrolled asthma and 
the proportion of subjects with controlled asthma 
raised to 3.8%; it should be emphasized that 
assessing asthma control with only symptoms 
usually overestimates the result (7). For this 
reason, using the GINA based algorithm that 
includes PFT is more reliable.  
The results observed were similar with the 
worldwide severity and control of asthma in the 
AIR trial in North America, Europe, Japan and the 
Asia-Pacific region with data from 10,939 patients 
in 29 countries (8).  Another study in North 
Africa, the Maghreb Study, showed only 7.6% of 
the subjects were considered to have controlled 
and 50.9% to have uncontrolled asthma when the 
GINA based algorithm was used (7).    
Using the ACT score also, a high number of 
individuals 167(71.4%), scored <19 that 
corresponds to poor control of asthma in the 




current study. Sixty-six (28.6%) individuals 
scored 20 and above which classified them as 
having well-controlled asthma, which is a better 
estimate of asthma control compared with results 
that used the GINA algorithm.  
Another study done in Vietnam predicted 
GINA defined 'not controlled asthma' with a 
sensitivity of 70% and specificity of 93%. The 
questionnaire score correlated well with treatment 
modifications and lung function parameters 
(FEV1 and PEF). The ACT is easily and quickly 
completed by patients and can serve as a useful 
tool in everyday practice to guide adjustments in 
asthma therapy (9). The GINA guideline on the 
other hand is based on expert consensus and has 
not yet been validated in real world practice (10, 
11). Thus, the ACT is a more suitable instrument 
for assessing control when patients are directly 
asked about their symptoms (3).    
This finding is comparable with a recent pan-
European cross-sectional survey done in 2008, 
with results of 57% of adult asthmatics had 'not 
well-controlled' asthma on a validated symptom 
instrument, with no improvement since 2006 
(ACT score <19) (12). 
The poor level of control likely resulted from 
the relatively very low proportion of respondents 
using the recommended prophylactic controller 
medication. Only 9 subjects (3.8%) used inhaled 
corticosteroids alone or in association with long-
acting b-agonists. Most of the patients used only 
medications that quickly relieve asthma 
symptoms, but that has no role in controlling the 
underlying inflammation of the airways.   
Although lower use of these controller 
medications is reported in different studies, a 
higher proportion of individuals do get the 
treatment in comparison with the asthmatic 
patients in the current study. For example, inhaled 
corticosteroids alone or in association with long-
acting b-agonists, which are the prophylactic 
treatments recommended by GINA, were used by 
163 subjects (26.1%) in North African AIRMAG 
study (3).  Drug Utilization Assessment in Asthma 
Therapy in India done on 100 asthmatic patients in 
2006 showed that 56% of the patients used inhaled 
corticosteroids during the study period (13).  
The low use of inhaled corticosteroid, besides 
the readily unavailability of the drug, could be 
explained by the higher price of the medication 
than the other symptomatic treatments which can 
relieve but not control asthma. These drugs are 
often taken without prescriptions and may lead the 
patient to self-treatment.  
Another factor associated with asthma control 
in the study was personal rate of asthma control in 
the past four weeks p<0.001 (OR=0.051 95% CI 
(0.020-0.128)). Eighty three individuals (71%) 
reported their asthma to be rated as uncontrolled 
among the study group with really poorly 
controlled asthma 117(76.1%) when they were 
assessed by GINA that included spirometric 
assessment. From patients with severe persistent 
asthma, 37(86%) rated their asthma as poorly 
controlled. This is in contrast to the Asthma 
Insights and Reality in Europe (AIRE) study 
where approximately 50% of patients reporting 
severe persistent symptoms also considered their 
asthma to be completely or well-controlled (14). 
The high perceived rate of uncontrolled asthma in 
the current study can be explained by the poor 
underlying lung function result that showed 
56.25% of the study subjects had FEV1<80%.  
Finally, asthma control was also dependently 
associated with the individual patient’s age group, 
p=0.048 (OR=3.445 95% CI (1.009-11.766)). This 
finding was similar with the study done in the 
Netherlands, Disease control in the general 
practice patients with asthma, where patients 
inadequately controlled were usually older 
compared to those with a good disease control, 
(OR=2.3 95% CI (1.38-3.85)) (15).   
One of the potential limitations of this study 
was difficulty in obtaining the maximum 
respiratory effort to generate the FEV1. Only 160 
people (68%) were able to produce acceptable 
FEV1 measurements; the rest 74 (32%) could 
neither reproduce acceptable results nor excluded 
using the exclusion criteria. Therefore, they were 
assessed for control of asthma using GINA 
guidelines excluding LFT and by the standardized 
ACT questionnaire. The problems identified in the 
patients to reproduce acceptable results were lack 
of proper understanding on how to perform 
spirometry and fear of precipitating asthma 
symptoms by taking a deep and maximum breath. 
A second drawback is that the sample size of 
234 for whom asthma control was measured by 
the validated ACT measurement and 160 
individuals on whom appropriate spirometry was 
done, while being considerably enough, gives a 
reduced statistical power among subgroup 





multinomial analyses in patients taking different 
treatment and other subgroups (Table 3). 
Therefore, studies on larger samples are needed to 
monitor trends of asthma control and identify 
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